Cosmo Presents Agenda for AGM 2026

Rhea-AI Summary

Cosmo (OTC:CMOPF) has convened its Ordinary Annual General Meeting for 10 April 2026 in Amsterdam. Key agenda items include the Board report for 2025, appropriation of full-year 2025 results, a proposed distribution of €2.10 per share, a corporate name change to Cosmo N.V., director reappointments, adoption of remuneration policy, and authorisations to issue new ordinary and preferred shares.

Complete convening notice, explanatory notes and proxy, plus the Annual Report 2025 and ESG Report 2025, are available on the company website.

Positive

• Proposed distribution of €2.10 per share
• AGM scheduled for 10 April 2026 in Amsterdam
• Proposal to change corporate name to Cosmo N.V.
• Annual Report 2025 and ESG Report 2025 published online

Negative

• Board authorised to issue shares, implying potential share dilution
• Distribution reduces freely distributable reserves by the payout amount
• Director reappointments are limited to a one-year term

Dublin, Ireland--(Newsfile Corp. - March 12, 2026) - Cosmo Pharmaceuticals N.V. (“Cosmo”) is pleased to announce the convening of its upcoming Ordinary Annual General Meeting of Shareholders (AGM) to be held on 10 April 2026 in Amsterdam.

The agenda includes, among others, the following discussion and voting items:

• Report of the Board of Directors on the business year 2025 and the ESG achievements
• Appropriation of the Full-Year 2025 results
• Proposal to grant discharge to the members of the Board of Directors
• Proposal to adopt the proposed resolution of the Board of Directors to declare a distribution out of the Company’s freely distributable reserves (of EUR 2.10 per share)
• Proposal to amend the Articles of Association of Cosmo and change its name to Cosmo N.V.
• Proposal to adopt the Company's remuneration policy
• Proposal to reappoint the members of the Board of Directors standing for re-election for a period of one year
• Three proposals to authorise the Board of Directors to issue – and/or grant rights to subscribe for – ordinary shares and preferred shares

The convening notice with the complete AGM agenda items, the explanatory notes and the written proxy are all available on the Company’s website via www.cosmohealthconfidence.com/agm. Cosmo’s Annual Report 2025 and ESG Report 2025 can be found here: www.cosmohealthconfidence.com/key-financial-reports.

About Cosmo
Cosmo is a life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). We design, develop, and manufacture advanced solutions that address critical medical needs and raise the standard of care. Our technologies are trusted by leading global pharmaceutical and MedTech companies and reach patients and healthcare providers around the world. Guided by our purpose - Building Health Confidence - our mission is to empower patients, healthcare professionals, and partners by innovating at the intersection of science and technology. Founded in 1997, Cosmo is headquartered in Dublin, Ireland, with offices in San Diego (USA), and in Lainate, Rome, and Catania (Italy). For more information, visit www.cosmohealthconfidence.com.

For further information regarding the AGM 2026, please contact:
generalmeeting@cosmohc.com

Attachments
PDF - English

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/288242

FAQ

When and where is Cosmo (CMOPF) holding its AGM in 2026?

The AGM is scheduled for 10 April 2026 in Amsterdam. According to the company, the convening notice and full agenda are available on its investor website with supporting documents and proxy instructions.

How much is the proposed distribution per share for Cosmo (CMOPF)?

The company proposes a distribution of €2.10 per share. According to the company, this distribution would be declared from freely distributable reserves and is on the AGM agenda for shareholder vote.

What does the proposed name change to Cosmo N.V. mean for CMOPF shareholders?

A proposed corporate name change to Cosmo N.V. is on the AGM agenda. According to the company, this is an amendment to the Articles of Association and requires shareholder approval at the meeting.

Will Cosmo (CMOPF) seek authority to issue new shares at the AGM?

Yes. The AGM includes proposals to authorise the Board to issue ordinary and preferred shares. According to the company, these authorisations would permit share issuance and rights grants subject to shareholder approval.

Where can investors find Cosmo's Annual Report 2025 and ESG Report 2025?

Both reports are available online on the company website. According to the company, the Annual Report 2025 and ESG Report 2025 can be accessed at the key financial reports page linked from the AGM convening materials.

What governance items will CMOPF shareholders vote on at the AGM?

Shareholders will vote on discharge of directors, reappointments, remuneration policy, articles amendment and distribution. According to the company, the AGM agenda lists these governance and corporate actions for shareholder approval.